Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker FAF
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Steven A. Adams VP & Chief Accounting Officer | FAF First American Corporation | Sale | 0 | $75.43 | $0 Sale | Form 4 ↗ |
| Jul 24, 2026 | Steven A. Adams VP & Chief Accounting Officer | FAF First American Corporation | Sale | 3,253 | $74.99 | $243.9K Sale | Form 4 ↗ |
| May 5, 2026 | Lisa W. Cornehl SVP, Chief Legal Officer | FAF First American Corporation | Sale | 5,823 | $68.63 | $399.7K Sale | Form 4 ↗ |
| Apr 24, 2026 | Margaret M. McCarthy Director | FAF First American Corporation | Sale | 6,630 | $70.59 | $468.0K Sale | Form 4 ↗ |
| Feb 17, 2026 | Parker S. Kennedy Director | FAF First American Corporation | Buy | 30,000 | $67.92 | $2.0M Buy | Form 4 ↗ |
| Feb 17, 2026 | Parker S. Kennedy Director | FAF First American Corporation | Buy | 14,841 | $67.70 | $1.0M Buy | Form 4 ↗ |
| Feb 13, 2026 | Parker S. Kennedy Director | FAF First American Corporation | Buy | 15,000 | $67.17 | $1.0M Buy | Form 4 ↗ |
| Aug 28, 2025 | James L. Doti Director | FAF First American Corporation | Sale | 7,692 | $65.17 | $501.3K Sale | Form 4 ↗ |
| Aug 13, 2025 | Margaret M. McCarthy Director | FAF First American Corporation | Sale | 3,500 | $65.63 | $229.7K Sale | Form 4 ↗ |
| Feb 25, 2025 | Mark Edward Seaton EVP & Chief Financial Officer | FAF First American Corporation | Sale | 37,321 | $65.27 | $2.4M Sale | Form 4 ↗ |
| Feb 25, 2025 | Lisa W. Cornehl SVP, Chief Legal Officer | FAF First American Corporation | Sale | 3,057 | $65.49 | $200.2K Sale | Form 4 ↗ |
| Feb 24, 2025 | Mark Edward Seaton EVP & Chief Financial Officer | FAF First American Corporation | Sale | 12,679 | $64.28 | $815.0K Sale | Form 4 ↗ |
| Feb 14, 2025 | Dennis J. Gilmore Director | FAF First American Corporation | Sale | 1,826 | $64.13 | $117.1K Sale | Form 4 ↗ |
| Feb 14, 2025 | Dennis J. Gilmore Director | FAF First American Corporation | Sale | 110,145 | $63.59 | $7.0M Sale | Form 4 ↗ |
| Oct 29, 2024 | Steven A. Adams VP & Chief Accounting Officer | FAF First American Corporation | Sale | 2,337 | $63.76 | $149.0K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances